M��todos de estimativa de peso e altura na avalia����o de desnutri����o de pacientes com c��ncer

To calculate the estimated and actual height and weight measures in cancer patients, evaluate the correlation and concordance of these measures and to identify the malnutrition patients. 62 cancer patients, treated at the Amaral Carvalho Hospital (Ja��- SP). For classifi cation of nutritional status, the Patient-Generated Subjective Global Assessment, the Body Mass Index and the relationship with usual weight were used. For the estimated weight was used the algorithm Chumlea et al.7 and estimated height, the equation proposed by Chumlea et al.8 and Kwok & Whitelaw24. The Pearson Correlation Coeffi cient and the Intraclass Correlation Coeffi cient was calculated and simple linear regression was conducted. To compare the malnutrition detected by different methods, the Cochran���s Q test were performed. There was a strong and signifi cant correlation between the estimated and actual weight (r=0,95; CI95%=0,92-0,97; p<0,001) and excellent concordance (��=0,95). For height measurements, a signifi cant correlation was observed between the actual and estimated measurement the method Chumlea et al.8 (r=0,78; CI95%=0,66-0,86; p<0,001) and Kwok & Whitelaw24 (r=0,85; CI95%: 0,75-0,90; p<0,001). Concordance was ���Good��� (��=0,72) and ���Moderate��� (��=0,67) between the actual height and estimated by Chumlea et al.8 and Kwok & Whitelaw,24 respectively. There was a strong correlation between the actual and estimated weight and height measures. The reproducibility of the equation proposed by Chumlea et al.8 to calculate height was better. The nutritional status, the patients classifi ed as malnutrition was greater when using the Patient-Generated Subjective Global Assessment and the relationship with usual weight.

An��lise da frequencia do polimorfismo rs12979860 C/T no gene IL28B em pacientes acometidos por c��ncer g��strico

P��s-gradua����o em Pesquisa e Desenvolvimento (Biotecnologia M��dica) - FMB

Caracteriza����o dos mecanismos de a����o da imunoterapia intravesical com P-MAPA envolvendo as vias de sinaliza����o dor receptores Toll-like (TLR) 2 e 4 na progress��o do c��ncer de bexiga n��o-m��sculo invasivo

Coordena����o de Aperfei��oamento de Pessoal de N��vel Superior (CAPES)

Controle ��timo Aplicado em um Modelo de C��ncer

P��s-gradua����o em Matematica Aplicada e Computacional - FCT

As estrat��gias de coping e o impacto sofrido pela fam��lia quando um dos seus est�� em tratamento contra o c��ncer

The aim of the present study was to analyze the impact suffered by 40 people when discovering that one of their family members was diagnosed with cancer, to analyze their coping strategies and expectations towards the patient���s illness and future. The study made use of the Coping Strategies Inventory by Folkman and Lazarus. Results show that most of the patients��� caregivers are their married children, with an average age of 45.7 (dp=12.67), and gainfully employed. These family members reported the negative impact of the diagnosis, with the predominant feelings of sadness and fear of loss, even though they had a positive perspective about the future, expecting the patient���s recovery. As to the functional coping strategies, the most used were the resolution of problems, followed by social support; the least used was positive revaluation. As to the dysfunctional strategies, the most used ones were escape and avoidance and the least used was taking the responsibility for the illness. Conclusions are that despite suffering with the negative impact of the disease, the family members are optimistic about the patient���s future and seek to use strategies that solve the problem effectively, without blaming themselves for the patient���s illness.

Intera����o de fibroblastos associados ao c��ncer em co-cultura com linguagens tumorias mam��rias e a resposta terap��utica em o uso da melatonina

Coordena����o de Aperfei��oamento de Pessoal de N��vel Superior (CAPES)

Genistein reduces the noxious effects of in utero bisphenol A exposure on the rat prostate gland at weaning and in adulthood

Bisphenol A (BPA) is one hormonally active chemical with potential deleterious effects on reproductive organs, including breast and prostate. In contrast, genistein (GEN) is the major phytoestrogen of soy that presents potential protective effects against hormone-dependent cancers, including that of the prostate. Thus, pregnant Sprague-Dawley rats were treated with BPA at 25 or 250����g/kg/day by gavage from gestational day (GD) 10-21 with or without dietary GEN at 250��mg/kg/chow (���5.5��mg/kg/day). Then, male offspring from different litters were euthanized on post-natal day (PND) 21 and 180. At PND21, BPA 25 exposure induced early prostatic changes while dietary GEN attenuated some deleterious actions this xenoestrogen on epithelial cell proliferation levels, androgen receptor expression and prostatic architecture in male offspring. At PND180, a significant increase in incidence of prostatic multifocal inflammation/reactive hyperplasia and atypical hyperplasia were observed in male offspring from dams that received BPA 25. On the other hand, maternal GEN feeding attenuated some the adverse effects of BPA 25 on prostate disease at late-in-life. This way, the present findings point to preventive action of dietary GEN on deleterious effects of gestational BPA exposure in both early and late prostate development in offspring F1.

Criptorquidia e exposi����o in utero ao di(n-butil)-ftalato e �� acrilamida: avalia����o morfol��gica do dano testicular

Conselho Nacional de Desenvolvimento Cient��fico e Tecnol��gico (CNPq)

Efeitos das formula����es nanoestruturadas de doxorrubicina e cisplatina em dispers��o de ��xido de grafeno reduzido no tratamento da progress��o do c��ncer de bexiga N��o-m��sculo invasivo

Coordena����o de Aperfei��oamento de Pessoal de N��vel Superior (CAPES)

Investiga����o da evolu����o dos p��lipos endometriais em c��ncer de endom��trio

Funda����o de Amparo �� Pesquisa do Estado de S��o Paulo (FAPESP)

Modelo matem��tico de tratamento de c��ncer via quimioterapia em ciclos

Coordena����o de Aperfei��oamento de Pessoal de N��vel Superior (CAPES)

Preval��ncia de coinfec����o e fatores associados ao Papilomav��rus Humano (HPV) e �� Chlamydia tracomatis em mulheres em idade reprodutiva atendidas em Program de Preven��ao de C��ncer do Colo Uterino na regi��o sudeste do Brasil: sub-titulo / (se houver)

Conselho Nacional de Desenvolvimento Cient��fico e Tecnol��gico (CNPq)

Terapia g��nica com interferon-alfa no controle do c��ncer colorretal

Conselho Nacional de Desenvolvimento Cient��fico e Tecnol��gico (CNPq)

Sistemas precursores de cristais l��quidos mucoadesivos para administra����o bucal de curcumina no tratamento do c��ncer bucal

Funda����o de Amparo �� Pesquisa do Estado de S��o Paulo (FAPESP)

Biofilmes orais como um poss��vel fator de risco ao c��ncer bucal: revis��o da literatura

Introduction: much studies regarding risk factors associated with oral cancer. Factors such as smoking and alcohol and solar radiation are well established, but others, such as bacterial influence in the development or progression of a tumor still remain unexplained. Interest in the possible relationship between bacteria and different stages of cancer development has increased since the classification of H. pylori by the WHO as a definite carcinogen. Subsequently, links between infection and the onset of cancer in various sites in the body were discovered. Review of literature: this literature review attempts to show the influence of poor oral hygiene, with consequent bacterial accumulation as a possible important risk factor for the initiation and development of mouth cancer, and correlate the possible mechanisms by which bacteria can initiate or promote carcinogenesis. Conclusion: there is much evidence that bacteria in the oral cavity and periodontopathic are present in tumor tissue, however, still can not affirm that these bacteria initiate or promote carcinogenesis.